Apolipoprotein B (ApoB) Antibodies
This rabbit polyclonal antibody was generated against Apolipoprotein B (ApoB) and recognizes both isoforms of rat and mouse ApoB.
Highlights:
- React with rat and mouse ApoB
- Recognize apoB-100 and apoB-48 isoforms
- Suitable for Western Blot and Immunofluorescence applications
Apolipoprotein B (ApoB) is a major protein constituent of chylomicrons (apo B-48), LDL (apo B-100) and VLDL (apo B-100). Apo B-100 functions as a recognition signal for the cellular binding and internalization of LDL particles by the apoB/E receptor. High levels of ApoB have been shown to be related to heart disease.
From the laboratory of Larry L. Swift, PhD, Vanderbilt University.
This rabbit polyclonal antibody was generated against Apolipoprotein B (ApoB) and recognizes both isoforms of rat and mouse ApoB.
Highlights:
- React with rat and mouse ApoB
- Recognize apoB-100 and apoB-48 isoforms
- Suitable for Western Blot and Immunofluorescence applications
Apolipoprotein B (ApoB) is a major protein constituent of chylomicrons (apo B-48), LDL (apo B-100) and VLDL (apo B-100). Apo B-100 functions as a recognition signal for the cellular binding and internalization of LDL particles by the apoB/E receptor. High levels of ApoB have been shown to be related to heart disease.
From the laboratory of Larry L. Swift, PhD, Vanderbilt University.
| Catalog Number | Product | DataSheet | Size | AVAILABILITY | Price | Qty |
|---|
Specifications
| Product Type: | Antibody |
| Antigen: | Rat apolipoprotein (apo) B |
| Accession ID: | P04114 |
| Host: | Rabbit |
| Clonality: | Polyclonal |
| Reactivity: | Rat, Mouse |
| Buffer: | Whole serum |
| Tested Applications: | WB (1988 and 1995), IF (1988) |
| Comments: | Effective on immunoblots, recognizing both isoforms of mouse and rat apoB equally well |
| Storage: | -80C |
| Shipped: | Cold Packs (Domestic, Overnight); Dry Ice (International) |
Provider
From the laboratory of Larry L. Swift, PhD, Vanderbilt University.
References
- S. Tiwari, S Siddiqi, O. Zhelyabovska, and S.A. Siddiqi. 2016. Silencing of small valosin-containing protein-interacting protein (SVIP) reduces very low density lipoprotein (VLDL) secretion from rat hepatocytes by disrupting its endoplasmic reticulum (ER)-to-Golgi trafficking. J. BIol. Chem. 291: 12514-12526
If you publish research with this product, please let us know so we can cite your paper.
